Women Probiotics Women Probiotics


Preventing HPV Without a Vaccine is the Real Answer

A bill introduced by U.S. Rep. Phil Gingrey (R-GA) would eliminate any federal funding for human papillomavirus (HPV) vaccination programs.

Such a bill has little chance of getting through Congress on its own, but some believe it could be attached to the 2008 spending bill for the Department of Health and Human Services that may not be blocked at all.

At the same time, Virginia Gov. Timothy Kaine has requested $4 million in state funds to provide the vaccine for children of low-income families.

Preventative Medical Care

Wall Street Journal columnist Dr. Benjamin Brewer believes the real reason too many women die from cervical cancer has more to do with a lack of access by low-income women to preventative medical care than a vaccine.

He cites the development of newer, better Pap smears that has made cervical cancer a rarity in the United States by cutting down on false positive results and improving cancer screenings. Brewer has encountered just one case of cervical cancer over the past nine years in his practice.

News-Medical.net March 11, 2007

Wall Street Journal March 8, 2007

Dr. Mercola's Comment:

If you've read the myriad of articles appearing lately in the mainstream press, you'd assume the unnecessary Merck vaccine, Gardasil, is the only way known to man to prevent the human papillomavirus (HPV), the most common cause of cervical cancer, even though this cancer is almost completely avoidable with appropriate lifestyle habits.

But even if people choose not to avoid risky behaviors there is still a major question as to just how dangerous this virus really is. Although more than 6 million women contract HPV every year, just 2 percent of the patients participating in a recent study were infected with the kinds of HPV that put them at a higher risk of developing cervical cancer.

But nonetheless, just as various state legislatures fight about the dubious need for mandating a new and costly vaccine to treat the HPV virus, GlaxoSmithKline has announced that they will file an application with the FDA for an HPV vaccine of their own called Cervarix.

If the feds deem it necessary to grant Cervarix fast-track status, the vaccine -- just as unnecessary as Gardasil -- may be available by year's end.

Related Articles: